CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Aripiprazole

Last Updated: November 6, 2009
Result type: Reports
Project Number: S0183
Product Line: Reimbursement Review

Generic Name: Aripiprazole

Brand Name: Abilify

Manufacturer: Bristol-Myers Squibb Canada

Therapeutic Area: Schizophrenia

Indications: Schizophrenia

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: April 27, 2010

Recommendation Type: Do not list